A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

Concord Repatriation General Hospital, Concord

Epworth Healthcare, East Melbourne

St Vincents Hospital Melbourne, Fitzroy

IRCCS Istituto Clinico Humanitas, Rozzano MI

IRCCS Ospedale San Raffaele, Milan

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia

Azienda Ospedaliera Universitaria di Bologna Policlinico S Orsola Malpighi, Bologna

Universitätsklinikum Frankfurt/Main, Frankfurt am Main

Rush University Medical Center, Chicago

Hopital Saint Louis, Paris

Universitatsklinikum Ulm, Ulm

City of Hope National Medical Center, Duarte

Hopital Henri Mondor, Créteil Cedex

Hackensack University Medical Center, Hackensack

Universitaetsklinikum Carl Gustav Carus, Dresden

Leicester Royal Infirmary, Leicester